These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 18569926)

  • 1. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
    Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
    Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 1996; 47(4):209-14. PubMed ID: 9097714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T; Garola RE; Singh HK
    Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
    Nezhad ST; Momeni B; Basiratnia M
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and function of the glomerular filtration barrier].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis.
    Kemeny E; Mihatsch MJ; Dürmüller U; Gudat F
    Clin Nephrol; 1995 Feb; 43(2):71-83. PubMed ID: 7736682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
    Danilewicz M; Wagrowska-Danilewicz M
    Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
    Kuo HT; Kuo MC; Chiu YW; Chang JM; Guh JY; Chen HC
    Eur J Clin Invest; 2005 Apr; 35(4):245-50. PubMed ID: 15816993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study.
    Chiang ML; Hawkins EP; Berry PL; Barrish J; Hill LL
    Clin Nephrol; 1988 Jul; 30(1):8-14. PubMed ID: 3061695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
    Ahn W; Bomback AS
    Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach.
    Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
    J Clin Pathol; 2006 Sep; 59(9):916-20. PubMed ID: 16522749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L; Kopp JB
    Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.